Metaplastic Breast Carcinomas: Are They of Myoepithelial Differentiation?
Authors:
- 1 March 2005
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 29 (3) , 347-353
Abstract
We investigated 20 spindle cell (sarcomatoid) metaplastic carcinomas (MCs) without squamous differentiation. In addition, five high-grade phyllodes tumors were assessed for comparison. Our immunohistochemical antibody panel included pan-cytokeratin (CK), low molecular weight CK (CK8/18), four basal cell type CKs (34βE12, CK5/6, CK14, and CK17), vimentin antibodies, as well as antibodies to established (SMA, CD10, p63, S-100, maspin, calponin, GFAP, SM-myosin), and novel (CD29, 14-3-3σ) myoepithelial markers. Sixteen of the 20 tumors (80%) expressed at least two markers of the combination CD10/p63/SMA. S-100 detected 1 case negative for CD10/p63/SMA and 3 cases that only expressed one marker of this combination. While 18 MCs (90%) were positive for CD29, 14-3-3σ (11 cases) and maspin (9 cases) were observed in 55% and 45%, respectively. Antibodies to pan-CK and the basal cell type CKs were strongly reactive in 12 tumors (60%), but in 6 cases (30%) positivity for these markers was weak and only focal; 2 MCs showed no positivity for CK. The stromal component of all phyllodes tumors was positive for vimentin, whereas all other investigated markers were absent except for focal p63 and CD10 expression in 1 case each. Our findings convincingly show a myoepithelial immunophenotype in sarcomatoid MCs, which is demonstrated by the presence of basal cell type CKs and the combination of the established myoepithelial markers CD10, p63, SMA, and S-100. We conclude that tumors with weak or even absent CK expression should only be diagnosed as primary sarcomas of the breast after exclusion of a myoepithelial immunophenotype. CD29 and 14-3-3σ represent valuable novel myoepithelial markers in these diagnostically difficult cases.Keywords
This publication has 25 references indexed in Scilit:
- An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breastHuman Pathology, 2003
- Basal Cells of Second Trimester Fetal Breasts: Immunohistochemical Study of Myoepithelial PrecursorsPediatric and Developmental Pathology, 2003
- Wide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patientsHistopathology, 2002
- Sarcomatoid/metaplastic carcinoma of the breast: a clinicopathological study of 12 casesHistopathology, 2002
- CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasmsHistopathology, 2001
- p63, a p53 Homologue, Is a Selective Nuclear Marker of Myoepithelial Cells of the Human BreastAmerican Journal of Surgical Pathology, 2001
- Utility of CD10 in Distinguishing between Endometrial Stromal Sarcoma and Uterine Smooth Muscle Tumors: An Immunohistochemical Comparison of 34 CasesLaboratory Investigation, 2001
- Carcinomas of the breast showing myoepithelial cell differentiationVirchows Archiv, 1998
- Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue.Proceedings of the National Academy of Sciences, 1993
- Carcinoma of the breast with pseudosarcomatous metaplasiaCancer, 1984